2017 to 2022 Saw Significant Rise in Injuries From E-Bikes, E-Scooters

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, July 24, 2024 -- The number of electric scooter and bicycle injuries increased significant from 2017 to 2022, according to a study published online July 23 in JAMA Network Open.

Adrian N. Fernandez, M.D., from the University of California in San Francisco, and colleagues characterized micromobility injury trends in the United States, including demographic characteristic differences for users of electric and conventional vehicles and factors associated with hospitalization. Analysis included data from the National Electronic Injury Surveillance System (2017 to 2022).

The researchers found that annual e-bicycle injuries increased from 751 to 23,493, while e-scooter injuries increased from 8,566 to 56,847. Electric vehicle accidents involved older individuals (median age, 31 versus 27 years) and a higher proportion of Black riders (25 versus 12 percent), compared with conventional vehicles. Electric vehicle incidents had lower helmet use compared with conventional vehicles (43 versus 52 percent), and injuries were more common in urban settings (83 versus 71 percent). For Black versus White individuals, age-adjusted odds of hospitalization were 24 percent lower.

"The findings from this study suggest that safer riding infrastructure and rider practices are important to curtail the rise of micromobility injuries," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-25 07:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords